Wealthfront Advisers LLC Buys 6,180 Shares of Intuitive Surgical, Inc. $ISRG

Wealthfront Advisers LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.4% during the 4th quarter, Holdings Channel reports. The fund owned 46,256 shares of the medical equipment provider’s stock after purchasing an additional 6,180 shares during the period. Wealthfront Advisers LLC’s holdings in Intuitive Surgical were worth $26,198,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. lifted its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Caitlin John LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.3%

Shares of Intuitive Surgical stock opened at $470.99 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $427.84 and a twelve month high of $603.88. The business has a 50-day moving average price of $477.17 and a 200 day moving average price of $516.57. The firm has a market cap of $166.81 billion, a PE ratio of 57.09, a P/E/G ratio of 3.88 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the previous year, the business earned $1.81 EPS. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.51 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares in the company, valued at approximately $782,321.13. The trade was a 28.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 5,413 shares of company stock valued at $2,681,362. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on ISRG shares. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Leerink Partners decreased their price objective on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. UBS Group reduced their target price on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. The Goldman Sachs Group lifted their price target on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. Finally, BTIG Research reaffirmed a “buy” rating and set a $574.00 price target on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $581.91.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.